Clinical Trials Logo

Sedation clinical trials

View clinical trials related to Sedation.

Filter by:

NCT ID: NCT05554965 Recruiting - Sedation Clinical Trials

Endoscopic Hemostatic and Sedative Treatment of Esophageal and Gastric Variceal Bleeding

Start date: February 10, 2022
Phase: Phase 4
Study type: Interventional

Remazolam besylate was used for sedation during endoscopic hemostasis in patients with esophageal and gastric varices rupture and bleeding in liver cirrhosis. The onset time, recovery time and incidence of adverse reactions were observed.

NCT ID: NCT05495477 Recruiting - Respiratory Failure Clinical Trials

Effects of NIV and CPAP on Ventilation Distribution, Measured by EIT, During Deep Sedation in Paediatric Patients

NIVEIT-ped
Start date: April 20, 2021
Phase: N/A
Study type: Interventional

In patients undergoing spontaneous breathing (SB) deep sedation there is a re-distribution of ventilation towards lungs non-dependant areas (ventral areas in supine position). Non-invasive ventilation (NIV), offering positive pressure, should favour a better ventilation of dependant areas (dorsal areas in supine position), making ventilation more homogeneous and increasing functional residual capacity. Electrical impedance tomography (EIT) is a non-invasive, non-operator dependent, bedside, radiations-free diagnostic tool, feasible in paediatric patients and repeatable; it allows to study ventilation distribution, and it can measure and calculate also parameters that are related to the homogeneity of ventilation and the response to certain therapeutic maneuvers, such as anaesthesia or PEEP-application. Uses of EIT in paediatric age are described in literature, but it has never been described as being used in Non-Operating Room Anaesthesia, nor in other cases of SB deep sedation. In addition, the impact of NIV on the distribution of ventilation in healthy paediatric patients undergoing deep sedation has never been described.

NCT ID: NCT05397301 Completed - General Anesthesia Clinical Trials

Controlled Sedoanalgesia in External DCR Surgery

Start date: February 7, 2020
Phase: N/A
Study type: Interventional

In our study, we aim to compare general anesthesia and controlled sedoanalgesia methods in dacryocystorhinostomy (DCR) surgery in terms of hemodynamic data, bleeding amount, postoperative complications (bleeding, pain, etc.) and anesthesia satisfaction in a prospective and randomized controlled manner.

NCT ID: NCT05327296 Active, not recruiting - Sedation Clinical Trials

Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)

INSPiRE-ICU2
Start date: June 30, 2022
Phase: Phase 3
Study type: Interventional

This is a study to compare safety and efficacy of inhaled isoflurane administered via the Sedaconda ACD-S device system versus intravenous propofol for sedation of mechanically ventilated patients in the Intensive Care Unit (ICU) setting.

NCT ID: NCT05312385 Active, not recruiting - Sedation Clinical Trials

Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1)

INSPiRE-ICU1
Start date: April 28, 2022
Phase: Phase 3
Study type: Interventional

This is a study to compare safety and efficacy of inhaled isoflurane administered via the Sedaconda ACD-S device system versus intravenous propofol for sedation of mechanically ventilated patients in the Intensive Care Unit (ICU) setting.

NCT ID: NCT05305248 Completed - Sedation Clinical Trials

Sedation With Remimazolam During Spinal Anesthesia

Start date: April 19, 2022
Phase: N/A
Study type: Interventional

Remimazolam is a benzodiazepine-binding site antagonist of the GABA receptor, metabolized by esterases, and exhibits a stable context-sensitive half-life of 6-7 minutes. Remimazolam has a high clearance rate and a small volume of distribution in the pharmacokinetic model. The US FDA has approved sedation for surgery. Although there have been studies on the use of remimazolam as a sedative for procedures such as endoscopy, there have been no reports of the use of remimazolam in spinal anesthesia. The purpose of this study is to compare and analyze the hemodynamics and recovery profile of patients undergoing surgery under spinal anesthesia by maintaining sedation with dexmedetomidine or remimazolam.

NCT ID: NCT05274984 Recruiting - Sedation Clinical Trials

Lidocaine Infusion for Propofol Dose Reduction in ERCP Procedure

Start date: January 3, 2022
Phase: Phase 1
Study type: Interventional

This study aims to investigate the dose reduction of propofol if associated with continuous infusion of lidocaine during ERCP procedures in patients over 65 years old.

NCT ID: NCT05272306 Completed - Anesthesia Clinical Trials

Gastro-laryngeal Tube During Transesophageal Echocardiography

GLT
Start date: April 13, 2022
Phase: N/A
Study type: Interventional

To analyze the effects of the use of Gastro-laryngeal Tube on intraoperative and postoperative hemodynamics, procedure comfort, and cardiologist and patient satisfactions during transesophageal echocardiography.

NCT ID: NCT05082623 Active, not recruiting - Pain Clinical Trials

The Effect of Music on Delirium, Pain, Need of Sedation, Anxiety and Vital Parameters

Start date: September 14, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effect of a twice daily, 60-minute, nurse initiated, music listening intervention on patients followed in the ICU with MV support as compared to patients who receive care as usual and ear plugs.

NCT ID: NCT05071352 Recruiting - Critical Illness Clinical Trials

Adjuvant Continuous Infusion of Nefopam Versus Standard of Care in Mechanically Ventilated Critically Ill Patients: Randomized Double-blind Controlled Study

Start date: October 1, 2021
Phase: Phase 3
Study type: Interventional

The aim of this prospective, randomized, active control, double blinded study is to assess the effect and safety of continuous infusion nefopam in mechanically ventilated ICU patients compared to standard of care. It is being hypothesized that continuous infusion nefopam will reduce opioid use with acceptable safety profile compared to standard of care.